Keyphrases
Acute Rejection
28%
African American
26%
Alloantigen
16%
Allogeneic
23%
Allograft
20%
Brain Death
24%
Clinical Outcomes
26%
Complement Inhibitors
23%
COVID-19
28%
Donor Organs
15%
Endothelial Cells
27%
Graft Loss
25%
Graft Outcome
16%
Graft Survival
16%
Heart Valve
20%
Human Regulatory T Cells
31%
Humanized Mouse Model
17%
Immunogenicity
20%
Immunosuppression
15%
Ischemia-reperfusion Injury
54%
Kidney
18%
Kidney Transplant
22%
Kidney Transplant Recipients
35%
Kidney Transplantation
51%
Liver
28%
Liver Transplantation
92%
Living Donor
16%
Lung
25%
Lung Transplantation
28%
Nanoparticles
23%
Nanotherapeutics
28%
Organ Transplantation
43%
Orthotopic Liver Transplantation
33%
Pancreas Transplantation
15%
Pediatric Liver Transplantation
31%
Pediatric Patients
17%
Pretransplant
19%
Prospective Randomized Trial
15%
Randomized pilot Trial
15%
Rapamycin
23%
Readmission
17%
Regulatory T Cells
20%
Renal Transplant Recipients
27%
Risk Factors
28%
Solid Organ Transplantation
37%
T Cells
26%
Transplant Arteriosclerosis
39%
Transplant Recipients
17%
Transplantation
82%
Treg
30%
Medicine and Dentistry
Acute Graft Rejection
21%
Allograft
40%
Arteriosclerosis
33%
Chronic Graft Rejection
11%
Cohort Analysis
14%
Complement Inhibitor
15%
Cross Sectional Study
11%
Cryopreservation
12%
Delayed Graft Function
17%
Diabetes
13%
Diabetes Mellitus
12%
Diseases
18%
End Stage Renal Disease
15%
Endoplasmic Reticulum Stress
13%
Endothelial Cell
15%
Epstein Barr Virus
11%
Ex Vivo
36%
Graft Failure
27%
Graft Rejection
15%
Graft Survival
31%
Health Care Cost
31%
Hepatic Portal Vein
11%
Human T Regulatory Cell
31%
Immunogenicity
12%
Immunosuppressive Drug
11%
Infection
16%
Inferior Vena Cava
15%
Kidney Graft
76%
Kidney Transplantation
55%
Liver Cirrhosis
11%
Liver Graft
31%
Liver Transplantation
100%
Living Donors
19%
Lung
21%
Neoplasm
17%
Organ Transplantation
27%
Pancreas Transplantation
27%
Pediatrics
46%
Pediatrics Patient
13%
Peripheral Blood Mononuclear Cell
13%
Pulmonary Fibrosis
17%
Rapamycin
24%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Solid Organ Transplantation
21%
Stenting
11%
Systemic Scleroderma
15%
T Cell
35%
Tacrolimus
11%
Transplant Surgeon
15%
Vascularity
13%
Immunology and Microbiology
Acute Graft Rejection
23%
Alloantigen
24%
Allograft
52%
Autoantibodies
14%
Autophagy
9%
CD25
13%
CD4
13%
Cell Function
7%
Chronic Graft Rejection
25%
Cold Ischemia
9%
Complement Activation
11%
Complement Inhibitor
23%
Cytomegalovirus
7%
Endoplasmic Reticulum Stress
13%
Heart Valve
7%
Human T Regulatory Cell
31%
Humanized Mouse
19%
Immune Privilege
7%
Immunocompetent Cell
13%
Immunogenicity
21%
Immunoglobulin G
9%
Immunosuppressant
9%
Immunosuppression
26%
Immunosuppressive Drug
27%
Kidney Transplantation
24%
Liver Transplantation
23%
Lung Transplantation
24%
Macrophage
15%
Mediator
7%
Micelle
10%
Mouse Model
30%
Myeloid-Derived Suppressor Cell
7%
Opportunistic Infection
15%
Organ Transplantation
25%
Pancreas Transplantation
15%
Perfusion
10%
Peripheral Blood Mononuclear Cell
9%
Proinflammatory Cytokine
10%
Regulatory Cell
9%
Regulatory T Cell
51%
Reperfusion
55%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Sirolimus
22%
Solid Organ Transplantation
35%
Solution and Solubility
12%
T Cell
48%
T-Helper Cell
13%
Transplant Rejection
32%
Transplantation Research
7%
Transplantation Tolerance
7%